Literature DB >> 34006978

Neuromodulation and neuroprotective effects of chlorogenic acids in excitatory synapses of mouse hippocampal slices.

Mara Yone D Fernandes1,2, Fernando Dobrachinski1,3, Henrique B Silva1, João Pedro Lopes1, Francisco Q Gonçalves1, Felix A A Soares3, Lisiane O Porciúncula4, Geanne M Andrade2, Rodrigo A Cunha5,6, Angelo R Tomé1,7.   

Abstract

The increased healthspan afforded by coffee intake provides novel opportunities to identify new therapeutic strategies. Caffeine has been proposed to afford benefits through adenosine A2A receptors, which can control synaptic dysfunction underlying some brain disease. However, decaffeinated coffee and other main components of coffee such as chlorogenic acids, also attenuate brain dysfunction, although it is unknown if they control synaptic function. We now used electrophysiological recordings in mouse hippocampal slices to test if realistic concentrations of chlorogenic acids directly affect synaptic transmission and plasticity. 3-(3,4-dihydroxycinnamoyl)quinic acid (CA, 1-10 μM) and 5-O-(trans-3,4-dihydroxycinnamoyl)-D-quinic acid (NCA, 1-10 μM) were devoid of effect on synaptic transmission, paired-pulse facilitation or long-term potentiation (LTP) and long-term depression (LTD) in Schaffer collaterals-CA1 pyramidal synapses. However, CA and NCA increased the recovery of synaptic transmission upon re-oxygenation following 7 min of oxygen/glucose deprivation, an in vitro ischemia model. Also, CA and NCA attenuated the shift of LTD into LTP observed in hippocampal slices from animals with hippocampal-dependent memory deterioration after exposure to β-amyloid 1-42 (2 nmol, icv), in the context of Alzheimer's disease. These findings show that chlorogenic acids do not directly affect synaptic transmission and plasticity but can indirectly affect other cellular targets to correct synaptic dysfunction. Unraveling the molecular mechanisms of action of chlorogenic acids will allow the design of hitherto unrecognized novel neuroprotective strategies.

Entities:  

Year:  2021        PMID: 34006978     DOI: 10.1038/s41598-021-89964-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  66 in total

1.  Ten-year anniversary of the European Brain Council: the major achievements.

Authors:  J Olesen
Journal:  Eur J Neurol       Date:  2012-06-30       Impact factor: 6.089

2.  Coffee, tea and caffeine intake and the risk of severe depression in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study.

Authors:  Anu Ruusunen; Soili M Lehto; Tommi Tolmunen; Jaakko Mursu; George A Kaplan; Sari Voutilainen
Journal:  Public Health Nutr       Date:  2010-04-01       Impact factor: 4.022

Review 3.  Coffee, tea, caffeine and risk of depression: A systematic review and dose-response meta-analysis of observational studies.

Authors:  Giuseppe Grosso; Agnieszka Micek; Sabrina Castellano; Andzrej Pajak; Fabio Galvano
Journal:  Mol Nutr Food Res       Date:  2015-11-23       Impact factor: 5.914

4.  Coffee, caffeine, and risk of depression among women.

Authors:  Michel Lucas; Fariba Mirzaei; An Pan; Olivia I Okereke; Walter C Willett; Éilis J O'Reilly; Karestan Koenen; Alberto Ascherio
Journal:  Arch Intern Med       Date:  2011-09-26

Review 5.  Coffee, Caffeine, and Health Outcomes: An Umbrella Review.

Authors:  Giuseppe Grosso; Justyna Godos; Fabio Galvano; Edward L Giovannucci
Journal:  Annu Rev Nutr       Date:  2017-08-21       Impact factor: 11.848

Review 6.  Mitochondria: the missing link between preconditioning and neuroprotection.

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers.

Authors:  Youngyo Kim; Youjin Je; Edward Giovannucci
Journal:  Eur J Epidemiol       Date:  2019-05-04       Impact factor: 8.082

Review 8.  Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes.

Authors:  Robin Poole; Oliver J Kennedy; Paul Roderick; Jonathan A Fallowfield; Peter C Hayes; Julie Parkes
Journal:  BMJ       Date:  2017-11-22

9.  Serum 25-Hydroxyvitamin D Concentrations and Major Depression: A Mendelian Randomization Study.

Authors:  Karl Michaëlsson; Håkan Melhus; Susanna C Larsson
Journal:  Nutrients       Date:  2018-12-15       Impact factor: 5.717

View more
  3 in total

1.  Structural Investigation of the Interaction Mechanism between Chlorogenic Acid and AMPA Receptor via In Silico Approaches.

Authors:  Wei Zhu; Fengming Wu; Jindie Hu; Wenjing Wang; Jifeng Zhang; Guoqing Guo
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

2.  Chlorogenic Acid Decreases Glutamate Release from Rat Cortical Nerve Terminals by P/Q-Type Ca2+ Channel Suppression: A Possible Neuroprotective Mechanism.

Authors:  Yi-Chieh Hung; Yi-Hsiu Kuo; Pei-Wen Hsieh; Ting-Yang Hsieh; Jinn-Rung Kuo; Su-Jane Wang
Journal:  Int J Mol Sci       Date:  2021-10-23       Impact factor: 5.923

3.  Identification of a Hydroxygallic Acid Derivative, Zingibroside R1 and a Sterol Lipid as Potential Active Ingredients of Cuscuta chinensis Extract That Has Neuroprotective and Antioxidant Effects in Aged Caenorhabditis elegans.

Authors:  Shimaa M A Sayed; Saleh Alseekh; Karsten Siems; Alisdair R Fernie; Walter Luyten; Christian Schmitz-Linneweber; Nadine Saul
Journal:  Nutrients       Date:  2022-10-09       Impact factor: 6.706

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.